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Abstract 
This paper investigates the reliability and validity of the Chinese version of the Fear 
of Cancer Recurrence Questionnaire-7 (FCR-7). A total of 1025 cancer patients were 
recruited and asked to complete the Chinese FCR-7, FoP-Q-SF, PHQ-9, and GAD-7. 
The internal consistency and test-retest reliabilities were examined. EFA and CFA was 
conducted on random split-half samples. Overall relationships of FCR-7 with other 
psychological constructs were examined. The Chinese FCR-7 showed good internal 
consistency (Cronbach’s alpha = 0.87), test-retest reliability (r = 0.90), and item-total 
correlations (ranged from 0.583 to 0.872). The unitary factor structure was 
supported by the EFA and the CFA fit statistics (CFI = 0.99; RMSEA = 0.039, 95%CI: 
0.01, 0.07). The total score of FCR-7 was positively associated with FoP-Q-SF (r = 
0.756, P < .01), PHQ-9 (r = 0.522, P < .01), and GAD-7 (r = 0.553, P < .01). Patients 
with low monthly income (P < .001), family cancer history (P = .012), and those who 
had gone through chemotherapy (P = .001) tended to report higher FCR. The FCR-7 
has been translated and successfully culturally adapted into a Chinese version. It is a 
reliable and valid measurement for assessing FCR. 
 
Keywords: cancer, Chinese, Fear of recurrence, psychometric properties 
Word count：Abstract: 195; Full Text: 3490 
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1. Introduction 
In the recent decade, Fear of Cancer Recurrence (FCR) has received growing 
attention in research with many cancer survivors of various cancer diagnoses (Cohee 
et al., 2015). FCR is often defined as: fear, worry, or concern relating to the possibility 
that cancer will come back or progress (Lebel et al., 2016). Patients with high FCR 
often reported significant psychological distress (i.e. depression) as well as negative 
behavior change (i.e. avoidance, excessive self-examination) (Avis et al., 2005; Lasry 
& Margolese, 1992; Lebel, Rosberger, Edgar, & Devins, 2009; Simard, Savard, & Ivers, 
2010). This concern may appear immediately after cancer diagnosis/treatment and 
has been shown to remain stable for years (Simard & Savard, 2009). 
 
Recent study showed that about 24-40% of cancer patients reported moderate to 
high levels of need for help dealing with FCR (Hartl, 2003; Hodgkinson, Butow, Hunt, 
Pendlebury, Hobbs, Lo, et al., 2007; Hodgkinson, Butow, Hunt, Pendlebury, Hobbs, & 
Wain, 2007). A systematic review (Simard et al., 2013) of previous studies found that 
survivors diagnosed at a young age, female, and with higher education level were 
more likely to suffer FCR compared with their counterparts. Meta-analysis showed 
that having had a mastectomy (Koch, Jansen, Brenner, & Arndt, 2013), radiotherapy 
(Yang, Cameron, & Humphris, 2016) or chemotherapy (Yang, Wen, Bedi, & Humphris, 
2017) were strong predictors of higher FCR. Other demographic and clinical factors, 
such as marital status, employment, cancer stage, and treatment type were still 
conflictive. 
 
Several measurements have been developed and utilized to assess FCR. Thewes and 
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colleagues (Thewes et al., 2012) completed a review of existing FCR measurements in 
2012, ranging from 2-item questionnaires to a 43-item questionnaire, and eventually 
they found 20 unique self-reported FCR assessment tools. Fear of Cancer Recurrence 
Inventory (FCRI) (Simard & Savard, 2009) was one of the commonly used 
questionnaires. This multi-item scale has the strength of evaluating a variety of 
qualities/features of FCR. However, it can be burdensome to complete, time-
consuming and challenging to score and interpret (Humphris, Watson, Sharpe, & 
Ozakinci, 2018). On the contrary, brief FCR questionnaire, such as the 2-item Fear of 
Recurrence Index (FRI) (Lasry & Margolese, 1992), even though was very easy to 
administer, it showed serious psychometrical weakness. Thus, researchers argued 
that short uni-dimensional FCR measure could be considered as the main instrument 
for assessing and screening patients (Humphris et al., 2018). 
 
In mainland China, only one FCR related scale has been translated and proved to be 
valid, that is, the Chinese version of the Fear of Progression Questionnaire-Short 
Form (FoP-Q-SF). In 2015, Wu et al. (Wu, 2015) investigated the reliability and validity 
of the Chinese FoP-Q-SF in 1031 liver cancer patients and confirmed that the scale 
was suitable for assessing FoP in Chinese cancer patients. However, no specific FCR 
instrument has been introduced in mainland China. 
 
The main purpose of this study is to translate and evaluate the psychometric 
properties of the 7-item Fear of Cancer Recurrence (FCR-7) questionnaire. This scale 
is based upon a set of 7 questions that have been selected from extant measures 
within the literature to assess directly FCR (Humphris et al., 2018). It has already 
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been utilized in numerous specific cancer populations, specifically in the UK (Rogers, 
Cross, Talwar, Lowe, & Humphris, 2016). The Flesch readability index test showed 
that the FCR-7 was equivalent to ‘Plain English, easily understood by thirteen- to 
fifteen-year-old students’ (Humphris et al., 2018). In the current study, we aimed to: 
1) translate the FCR-7 into Chinese and evaluate both the linguistic and cultural 
equivalence of the scale; 2) test its psychometric properties in a mixed group of 
Chinese cancer patients; 3) investigate the association of sociodemographic and 
clinical variables to FCR. 
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2. Methods 
2.1 Participants and settings 
A cross-sectional study was used. All participants were consecutively recruited from 
the department of Radiotherapy and Oncology (Nanfang Hospital, Level III tertiary 
hospital) and Guangdong Cancer Center (Guangdong General Hospital, Level III 
tertiary hospital). Data were collected from 1st January to 30th July 2018. Patients 
were eligible if they were: a) adults (above 18 years old); b) able to read, write and 
understand Mandarin or Cantonese; and c) with a cancer diagnosis. Excluded criteria 
were: a) patients who were blind/deaf; b) patients who had serious mental illness 
(i.e. schizophrenia); c) patients who received palliative treatment; or d) patients who 
had disturbance of consciousness. 
 
Overall, 1153 eligible patients were invited to participate, and 1025 of them agreed 
(response rate 89%). Of the 1025 participants, about 90% of the subjects were 
female and ranged in age from 20 to 90 years old (Mean = 48.29). Most of the 
patients were married, living with family members, and with low education 
background and monthly income. Nearly 80% of the patients had been diagnosed 
with breast cancer and many of them had received surgery (91.3%), chemotherapy 
(88.1%) and radiotherapy (87.5%). 
 
2.2 Instruments 
2.2.1 Personal Information Sheet 
A study specific set of questions (demographic/clinical sheet) were formulated to 
assess patient’s gender, age, marital, education, monthly income, employment 
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status, cancer stage, treatment type, family cancer history, and self-rated physical 
morbidity. The last three were measured by simple ‘Yes/No’ questions: 1) Did you 
received surgery/chemotherapy/radiotherapy? 2) Do you have a family cancer 
history? 3) Do you suffer from any other physical comorbidity, such as diabetes, 
hypertension, musculo-skeletal, etc.? For those who were uncertain about their 
cancer stage/treatment type, data were recollected from their medical records. 
 
2.2.2 Fear of Cancer Recurrence (FCR-7) questionnaire 
The 7-item FCR was developed at the University of St Andrews, Scotland by Professor 
Humphris and his colleagues. It is used to assess patient’s recurrence fears and has 
been used with patients with breast, colorectal and head and neck cancer in a variety 
of clinical centers in the UK (Rogers et al., 2016). The reliability of the questionnaire is 
good with an internal consistency of 0.92 (95%CI: 0.90, 0.94) and evidence for 
validity (Humphris et al., 2018). No cut-off has been reported other than the 
statistical 60th (score = 17) and 90th (score = 27) percentiles which have been 
regarded as levels for ‘moderate’ and ‘high’ reports of patient’s FCR respectively. 
 
2.2.3 Fear of Progression Questionnaire-Short Form (FoP-Q-SF) 
The 12-item FoP-Q-SF is a short form of the original Fear of Progression 
Questionnaire (FoP-Q) (Herschbach et al., 2005). It has been utilized to samples of 
various cancer patients by many countries (Mehnert, Berg, Henrich, & Herschbach, 
2009; Mehnert, Herschbach, Berg, Henrich, & Koch, 2006; Melchior et al., 2013). The 
items are scored on a 5-point Likert scale (from 1 = never, to 5 = very often). The total 
score of the scale ranges from 12 to 60, and higher total score indicates higher FoP. A 
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score of 34 or above indicates a dysfunctional level of FoP (Herschbach et al., 2010). 
The psychometric properties of the Chinese FoP-Q-SF has been tested by Wu and her 
colleagues (Cronbach’s alpha = 0.88) (Wu, 2015), but no cut-offs for dysfunctional has 
been provided in the Chinese version scale. 
 
2.2.4 Patient Health Questionnaire (PHQ-9) 
The 9-item Patient Health Questionnaire is a commonly used screening tool for 
depression in medical settings. It evaluates the degree of depressive symptoms, and 
the items range from 0 to 3 (0 = not at all, and 3 = nearly everyday) (Herschbach et 
al., 2010). A total score of 5 or more indicates depressive symptoms, and higher total 
score indicates higher depression level. The Chinese PHQ-9 shows satisfactory 
psychometric properties (internal consistency = 0.89) (Chen, 2015). 
 
2.2.5 General Anxiety Disorder Questionnaire (GAD-7) 
The 7-item General Anxiety Disorder Questionnaire is a brief self-report 
measurement used to evaluate person’s anxiety symptoms. Response options are not 
at all, several days, more than half the days, and nearly every day, rated as 0, 1, 2, 
and 3, respectively (Spitzer, Kroenke, Williams, & Lowe, 2006). A total score of 5 or 
more indicates anxiety symptoms, and higher total score indicates higher anxiety 
level. The internal consistency of the Chinese GAD-7 is 0.91 (Zheng, 2013). 
 
2.3 Procedure 
2.3.1 Translation 
The FCR-7 was translated according to the recommendations suggested by Bracken 
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and Barona (Bracken BA, 1991). In this study, the first author (YY) translated the FCR-
7 from English to Chinese, then two bilingual translators (professors working at the 
Southern Medical University, both had experience of translating and validating 
instruments) who blinded to the FCR-7 were asked to complete the back-translation. 
To make sure the meaning of each item was kept, a comparison was made between 
the original and the re-translated English versions. Disagreements were discussed 
and agreed upon by the researcher and both the back-translators. 
 
2.3.2 Data collection 
Approval for the study was obtained from the hospital Research Ethics Committee 
(ref No: NFEC-2018-038). Patients were approached by three co-authors (SHW, 
WHM, and LWJ) who are all chief physicians. After patients who showed interest in 
participating were told about the purpose of the study, a written informed consent 
form was provided. All patients were given the option of allowing or refusing their 
involvement in the study and then were asked to complete a personal information 
sheet, the FCR-7, FoP-Q-SF, PHQ-9, GAD-7 and returned to the research staff 
immediately. The whole procedure was supervised by the last author (ZB) who is an 
experienced licensed psychiatrist. 
 
2.4 Data analysis 
All statistical analyses were calculated with SPSS v16 and STATA 15. Normal 
distribution of all item scores and the total score was tested using the Kolmogorov–
Smirnow test. Item analysis was performed with calculation of means (M), standard 
deviations (SD), floor and ceiling effects. The items of the FCR-7 were tested with 
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part-whole correlated Pearson correlations between item and scale value. Content 
equivalence was established by an expert panel. Internal consistency was 
determined with Cronbach’s alpha, and bivariate correlations (Pearson’s r) with the 
FoP-Q-SF, PHQ-9, and GAD-7 were used to investigate convergent validity. Descriptive 
statistics were used to analyze the demographic/clinical data. Difference in means 
were investigated using a t test for independent samples. Analysis of variance were 
used to identify group effects. 
 
Item analysis 
Floor and ceiling effects were indicated when one fourth (25%)of the participants 
reported experiencing ‘not at all’ (floor effect) or ‘all the time’ (ceiling effect) (Fidika, 
Herle, Herschbach, & Goldbeck, 2015). The item-scale value correlations were 
calculated using Pearson’s correlation coefficients. Correlations above 0.40 are 
recommended, but correlations below 0.30 are usually considered unacceptably low 
(D. F. Polit & Beck, 2009). 
 
Content equivalence 
Content equivalence implies that each item in the instrument has consistent cultural 
relevance (Flaherty et al., 1988). Content equivalence of the Chinese FCR-7 was 
examined by a panel of experts. The panel included three oncologists (WHM, LWJ, 
and SHW), two clinical psychologists (ZJY, ZB) and a psychology nurse specialist (LT). A 
four-point scale (from 1=not relevant at all, to 4=very relevant) was completed by the 
experts to measure the relevancy of each item to the concept of FCR. The Content 
Validity Index (CVI), which indicates the percentage of the total items rated as either 
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three or four, was calculated. A CVI score of 80% or higher is considered to indicate 
good content validity (Waltz, 1988). 
 
Validity Test 
Convergent validity was measured by Pearson's correlation to examine the 
association between scores on the FoP-Q-SF, PHQ-9, GAD-7 and FCR-7. The Kaiser-
Meyer-Olkin test was conducted. The total sample was split randomly into two 
samples and EFA (using Horn’s parallel analysis: ‘paran’ command in STATA) was 
performed on one sample, and CFA was performed on the remaining sample. The 
goodness-of-fit indexes used included: X2/degrees of freedom (df) ratio, Comparative 
Fit Index (CFI), Root Mean Square Error of Approximation (RMSEA). The criteria for 
goodness-of-fit indexes are as followed: X2/d.f ≤ 3, CFI ≥ 0.95, RMSEA ≤ 0.08 (Li, 
Chung, Ho, Chiu, & Lopez, 2013). 
 
Reliability Test 
Internal consistency reliability of the Chinese version FCR-7 was assessed by 
calculating the Cronbach's alpha. Internal consistency reliability is acceptable with a 
Cronbach's alpha above 0.70, correlations of 0.80 and higher are highly desirable (D. 
F. Polit & Beck, 2009). A third of the participants were randomly selected (using a 
random number generator) to respond to the FCR-7 again by telephone after 1 
month, and test-retest reliability was assessed using Pearson’s r between the FCR-7 
total score at initial assessment and 1-month reassessment. 
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3. Results 
3.1 Participant Characteristics 
Patients who were older (P < .001), full-time employed (P = .005) and had been 
diagnosed with breast cancer (P < .001) tended to report lower FCR. On the contrary, 
patients with low monthly salary (P < .001), family cancer history (P = .012), and 
those who had gone through chemotherapy (P = .001) were more likely to 
experience higher FCR (table 1). One month later, 350 participants were invited by 
telephone to rate their FCR levels again and 285 of them completed the 
measurement (response rate 81%). Table 2 shows the comparison of demographic 
and clinical characteristics between patients of the initial assessment and retest 
measurement. Significant group difference was found in age (P = .037). 
 
3.2 Item Characteristics 
In the current study, floor effect was found for item 4 (33.4%), and no ceiling effects 
were found. The item-total scale correlations ranged from 0.583 to 0.872, which 
were all acceptable. Five out of seven items had high correlation (coefficients higher 
than 0.80, table 3). 
 
3.3 Content Equivalence 
The total CVI was 88% (ranged from 63 to 100%). The majority of the items were 
rated as quite or very relevant (score = 3 or 4), with the exception of item 6. Omitting 
item 6 the CVI was recalculated at 94% (ranged from 88 to 100%), which indicated 
that the content of most items reflected the underlying construct. 
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3.4 Validity Test 
The Kaiser-Meyer-Olkin test gave satisfactory high values of 0.91 for FCR-7, which 
meant sufficient variance to perform factor analysis. The EFA revealed single factor 
structure (eigenvalue for first factor = 4.26). The second factor adjusted eigenvalue 
was 0.037 which was below the random derived parallel eigenvalue of 0.19 which 
was averaged over 50 replications (see Supplementary file). This demonstrated that 
there was no evidence for a substantial second factor that comprised sufficient 
meaningful variance over the calculated random variation. The factor loadings for all 
items were high (> 0.7) with the exception of item 6 which was 0.578 (see table 3). 
The convergent validity of FCR-7 was assessed by calculating the correlations 
between FCR-7 total scores and the scores of FoP-Q-SF, PHQ-9 and GAD-7. Table 4 
shows that the FCR-7 total score was significantly associated with the other three 
instruments (r ranged from 0.522 to 0.756). The fit indices for the CFA were 
supportive of a single unidimensional scale. The fit was demonstrated by a X2/df fit 
index that was 1.79 and below recommended level of 3.0, CFI = 0.996; RMSEA = 
0.039 (95%CI: 0.01, 0.07). These numerical values provided reassurance that the 
items behaved psychometrically as expected. 
 
3.5 Reliability Test 
The Cronbach’s alpha of the scale was 0.87. Deletion of any item would not have 
indicated any improvements to internal consistency. As for the test-retest reliability, 
the Pearson’s correlation coefficient between initial and one-month reassessment 
was 0.90. 
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4. Discussion 
The main aim of this study was to translate a valid and reliable self-report scale for 
cancer recurrence fear, the FCR-7. Our results indicated that the Chinese version of 
the FCR-7 had satisfactory psychometric properties in Chinese cancer patients. 
 
Reliability, which refers to the consistency between independent measurements of 
the same concept/phenomenon, was a prerequisite for a valid scale (D. E. Polit, 
1997). Cronbach’s alpha is commonly used to evaluate an instrument’s reliability 
(Salkind, 2000). This study found that the Chinese FCR-7 scale has good internal 
consistency, with the Cronbach’s alpha = 0.87, which is slightly lower than the 
original scale that had been reported a coefficient of 0.92 (Humphris et al., 2018). 
Test-retest reliability with one-month interval was also assessed and considered 
satisfactory. However, we found that patients who completed reassessment were 
significantly younger than those at initial assessment. One possible reason is that 
younger participants were easier and more likely to be successfully reached by 
research staff because they used/answered their cell phones more frequently than 
older patients. Similar to earlier findings (Humphris et al., 2018), high item-total scale 
correlations (coefficients greater than 0.7) were found except for item 6. It is 
probably because item 6 focuses more on the behavioral response (self-examination 
behavior) to FCR while other items are describing the cognitive processing of FCR. 
 
Construct validity was supported by correlations observed between total scores on 
the Chinese FCR-7 and other three relevant instruments (FoP-Q-SF, PHQ-9, and GAD-
7). Our study found a significant positive relationship between FCR-7, FoP, anxiety 
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and depression scores. This finding is consistent with previous studies as researchers 
indicated that people with high levels of recurrence fears would tend to report more 
depressive, anxiety symptoms and psychological distress (Llewellyn, Weinman, 
McGurk, & Humphris, 2008; Thewes et al., 2013). In addition, positive association 
between FCR and HADS (Hospital Anxiety and Depression Scale) was also found by 
previous reports (Hinz, Mehnert, Ernst, Herschbach, & Schulte, 2015; Humphris et 
al., 2018; Simard, Savard, Gonthier, Tremblay, & Maheux, 2005; Simard et al., 2013). 
In accordance with the original scale (Humphris et al., 2018), the EFA revealed single 
factor structure and the factor loadings for most items were satisfactory (greater 
than 0.7). CFA was conducted on the remaining half sample to examine the scale’s 
factor structure more precisely, and the outcomes of the evaluation fit were all 
convincing, which confirmed a satisfactory fit between the hypothesized model and 
the data (Chan, Chow, & Lo, 2005). 
 
When compared with the Chinese FoP-Q-SF instrument, which is the only validated 
instrument measuring cancer patient’s recurrence fear in mainland China, the 
Chinese version of FCR-7 demonstrated similar internal consistency (0.87 in FCR-7 
versus 0.88 in FoP-Q- SF), better construct validity (CFI = 0.996, RMSEA = 0.039 in 
FCR-7 versus CFI = 0.902, RMSEA = 0.052 in FoP-Q- SF), satisfactory content validity, 
and appropriate convergent validity. 
 
In this study, we found that patients who were older and full-time employed tended 
to report lower FCR. These findings were consistent with several other FCR studies 
(Crist & Grunfeld, 2013; Hartl, 2003; Simard et al., 2013). It is reasonable to assume 
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that younger patients may consider their cancer as more unexpected (Simard et al., 
2013) and patients who are unemployed/part-time employed are under greater 
economic burdens compared to those who have stable monthly income (Skaali et al., 
2009). We also found that patients with a family cancer history were more likely to 
experience higher FCR. To our best knowledge, only one study reported family cancer 
history factor as a significant predictor of FCR (Dumalaon-Canaria, Prichard, 
Hutchinson, & Wilson, 2016). Thus, the link between family history and FCR is still 
weak and further investigations are needed. Our result showed that breast cancer 
patients tended to have less fear. However, conflictive evidences were reported, for 
example, Simard (Simard et al., 2010) and Kornblith (Kornblith et al., 2007) observed 
higher FCR among breast cancer women, while others found no significant 
association between cancer site and FCR (Simard et al., 2013). The inconsistent result 
we found in this investigation might be explained by the uneven samples of the study 
– nearly 80% of participants were female breast cancer patients. Another possible 
reason is the ‘cultural difference’ between the eastern and western patients since an 
individual’s illness perception might be influenced by the cultural system where they 
are located. Further studies with more male and mixed samples are needed. 
 
The strengths of this study are the relatively large sample size and inclusion of 
different cancer diagnoses. However, there are a number of limitations that should 
be acknowledged. First, nearly 80% of the participants are breast cancer patients and 
about 90% of them are female. A potential sample bias may exist because of the 
over-representation of female breast cancer patients and the small subsample of 
male participants may limit representativeness of our results. Second, only 2 
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southern hospitals were involved in this study, cancer centers in the middle and 
northern part of China were not included. The psychometric testing may be limited 
by the use of convenience sampling and the fact that the data recruitment sites are 
located in only one single city. Third, discriminant validity of the scale has not been 
examined in the current study. Further studies may consider investigating the 
correlations between scores on FCR-7 and health-related quality of life, 
psychological/social functioning, or overall well-being. A negative correlation may 
support the discriminant validity of the FCR-7. Fourth, many other important 
variables, such as time since cancer diagnosis, and surgery type were not examined 
in this study. Last but not least, cut-offs for dysfunctional/clinical significance of the 
Chinese FCR-7 have not been defined yet. 
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Conclusion 
The FCR-7 has been translated and successfully culturally adapted into a Chinese 
version. The scale demonstrated robust psychometric properties, suggesting that it is 
a reliable and valid measurement for assessing patient’s recurrence fear and may be 
considered to widely use in clinical service in mainland China. More validated 
Chinese instruments of FCR with clear cut-off values should be introduced and 
utilized in the future. 
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Table 1: Characteristics of Participants at Initial Assessment (n=1025) 
Sociodemographic n (%) FCR (M±SD) Statistics P value 
Gender     
Male 106 (10.3) 20.8±7.4   
Female 919 (89.7) 20.0±6.3 t=1.13 .259 
Age     
Age below 35 146 (14.2) 20.6±6.5   
Age between 35-60 675 (65.9) 21.8±7.0   
Age above 60 204 (19.9) 19.4±6.1 F=12.21 <.001 
Marital Status     
Single 72 (7.0) 20.6±6.6   
Married 879 (85.8) 20.1±6.4   
Divorced 40 (3.9) 18.3±6.5   
Widowed 34 (3.3) 20.1±6.9 F=1.16 .324 
Education Level     
High School or below 682 (66.5) 20.2±6.6   
Undergraduate 261 (25.5) 19.6±5.9   
Postgraduate or above 82 (8.0) 20.5±6.8 F=1.07 .342 
Living Arrangement     
Living alone 46 (4.5) 20.7±7.0   
Living with Family 955 (93.2) 20.1±6.4   
Living with Friends 24 (2.3) 17.5±6.1 F=2.12 .120 
Monthly Salary (Yuan)     
Less than 3000 474 (46.2) 21.1±6.7   
3000-5000 267 (26.0) 19.4±6.1   
5000-10000 202 (19.7) 18.9±6.0   
More than 10000 82 (8.0) 19.1±5.6 F=8.02 <.001 
Employment     
Full time 376 (36.7) 19.1±5.7   
Part time 55 (5.4) 20.0±5.8   
Unemployment 306 (29.9) 20.8±6.8   
Retired 288 (28.1) 20.4±6.7 F=4.29 .005 
Cancer Site     
Breast Cancer 803 (78.3) 19.8±6.2   
Lung Cancer 109 (10.6) 20.0±7.1   
Colorectal Cancer 84 (8.2) 21.5±6.7   
Nasopharynx Cancer 29 (2.8) 24.2±7.1 F=6.35 <.001 
Cancer Stage     
Stage 1 69 (6.7) 20.1±6.4   
Stage 2 352 (34.3) 20.5±6.7   
Stage 3 524 (51.1) 19.7±6.2   
Stage 4 80 (7.8) 20.1±6.8 F=1.03 .380 
Chemotherapy     
Yes 903 (88.1) 20.3±6.3   
No 122 (11.9) 18.2±6.7 t=-3.36 .001 
Radiotherapy     
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Abbreviation: M: mean; SD: standard deviation; 
 
Yes 897 (87.5) 20.2±6.3   
No 128 (12.5) 19.3±6.6 t=-1.47 .142 
Surgery     
Yes 936 (91.3) 20.1±6.5   
No 89 (8.7) 19.1±5.4 t=-1.78 .078 
Cancer Family History     
Yes 260 (25.4) 20.9±6.3   
No 765 (74.6) 19.8±6.3 t=-2.53 .012 
Physical Comorbidity     
Yes 671 (65.5) 19.6±6.3   
No 354 (34.5) 20.8±6.6 t=2.77 .006 
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Table 2: Comparison of Subjects at Initial and Retest Assessment 
Characteristics Initial test 
(n=1025) 
Re-test 
(n=285) 
t/x2 P 
Age (year) 48.29±11.88 46.7±11.1 2.09 .037 
Gender (male/female) % 10.3/89.7 7.0/93.0 2.83 .092 
Marital State (single/married 
/divorced/widowed) % 
7.0/85.8/3.9/3.3 6.0/87.4/2.8/3.9 1.36 .716 
Education (high school and below 
/Undergraduate/Postgraduate and above) % 
66.5/25.5/8.0 63.9/30.1/6.0 3.33 .189 
Living arrangement (alone/family/friend) % 4.5/93.2/2.3 5.6/89.5/4.9 6.01 .051 
Employment (full time/part time/unemployed/retired) % 36.7/5.4/29.9/28.1 39.6/6.7/28.8/24.9 2.11 .550 
Cancer site (breast/lung/colorectal /nasopharynx) % 78.3/10.6/8.2/2.8 80.4/9.8/5.3/4.6 4.88 .181 
Surgery (Yes/no) % 91.3/8.7 90.5/9.5 0.17 .678 
Chemotherapy (Yes/no) % 88.1/11.9 84.9/15.1 2.06 .152 
Radiotherapy (Yes/no) % 87.5/12.5 85.6/14.4 0.72 .398 
Comorbidity (Yes/no) % 65.5/34.5 67.0/33.0 0.24 .625 
Family Cancer History (Yes/no) % 25.4/74.6 25.6/74.4 0.01 .932 
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Table 3. Item Characteristics of the Chinese version FCR-7 (N=1025) 
Items M SD % Not at all % All the 
time 
r a loadings 
Q1: I am afraid that my cancer may recur 2.97 1.06 8.8% 10.9% .843** .868 
Q2: I am worried or anxious about the possibility of cancer 
recurrence 
2.79 1.01 9.6% 7.1% .872** .896 
Q3: How often have you worried about the possibility of getting 
cancer again 
2.70 0.88 6.5% 3.8% .846** .890 
Q4: I get waves of strong feelings about the cancer coming back 2.04 0.97 33.4% 2.7% .774** .775 
Q5: I think about the cancer returning when I didn’t mean to 2.44 0.91 15.3% 2.6% .804** .820 
Q6: I examine myself to see if I have physical signs of cancer 2.93 0.95 7.1% 4.1% .583** .578 
Q7: To what extent does worry about getting cancer again spill 
over or intrude on your thoughts and activities 
4.19 2.23 12.7% 1.0% .829** .749 
Note: validation data is based on scale in Chinese. **P< .01; a: item-total scale correlation; 
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Table 4. Correlations of the FCR-7 Total Score with FoP-Q-SF, PHQ-9 and GAD-7. 
 M±SD FCR-7 FoP-Q-SF PHQ-9 GAD-7 
FCR-7 20.05±6.41 1 .756** .522** .553** 
FoP-Q-SF 29.78±7.93  1 .573** .551** 
PHQ-9 5.13±4.92   1 .811** 
GAD-7 3.82±4.29    1 
**P < .01, M: mean; SD: standard deviation; FoP-Q-SF: Fear of Progression Questionnaire-Short 
Form; PHQ-9: Patient Health Questionnaire; GAD-7: General Anxiety Disorder Questionnaire; 
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Supplementary File:  Horn’s Parallel Analysis 
 
 
 
Note: The Horn’s Parallel Analysis showing eigenvalues for the 7 potential factors in the the FCR-7 with the 
random data points plotted in comparison with the adjusted. The crossover of the adjusted values between 
factors 1 and 2 and the randomly derived values from 50 averaged replications provides evidence of a strong 
uni-dimensional measurement structure for the Chinese FCR-7 scale. 
 
